20/06/2007 (Agence Europe) - At a meeting on 14-15 June, the European Medicines Agency (EMEA) and the US Food and Drug Administration (FDA) reviewed their cooperative activities (including on vaccines, oncology and pharmacogenomics) and agreed to expand this cooperation further, with the support of the European Commission, to paediatrics and medicinal products for rare diseases (“orphan drugs”). Furthermore, scientific dialogue has been widened to include extensions of therapeutic...